z-logo
open-access-imgOpen Access
Sweetening Pharmaceutical Radiochemistry by18F-Fluoroglycosylation: A Short Review
Author(s) -
Simone Maschauer,
Olaf Prante
Publication year - 2014
Publication title -
biomed research international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 126
eISSN - 2314-6141
pISSN - 2314-6133
DOI - 10.1155/2014/214748
Subject(s) - glycoconjugate , chemistry , radiochemistry , sweetening , combinatorial chemistry , in vivo , nucleophilic substitution , biochemistry , organic chemistry , sweetening agents , biology , microbiology and biotechnology , food science
At the time when the highly efficient [ 18 F]FDG synthesis was discovered by the use of the effective precursor 1,3,4,6-tetra- O -acetyl-2- O -trifluoromethanesulfonyl- β -D-mannopyranose (mannose triflate) for nucleophilic 18 F-substitution, the field of PET in nuclear medicine experienced a long-term boom. Thirty years later, various strategies for chemoselective 18 F-labeling of biomolecules have been developed, trying to keep up with the emerging field of radiopharmaceutical sciences. Among the new radiochemical strategies, chemoselective 18 F-fluoroglycosylation methods aim at the sweetening of pharmaceutical radiochemistry by providing a powerful and highly valuable tool for the design of 18 F-glycoconjugates with suitable in vivo properties for PET imaging studies. This paper provides a short review (reflecting the literature not older than 8 years) on the different 18 F-fluoroglycosylation reactions that have been applied to the development of various 18 F-glycoconjugate tracers, including not only peptides, but also nonpeptidic tracers and high-molecular-weight proteins.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom